Hepatocarcinogen-induced alterations in nuclear RNA compartmentation

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Nucleocytoplasmic RNA transport is crucial for gene expression.
• Disruptions in RNA transport are implicated in carcinogenesis.
• Existing in vitro assays have limitations in mimicking nuclear environment.

Purpose of the Study:

• To develop and validate a novel in vitro RNA transport assay.
• To investigate the role of polyvinylpyrrolidone (PVP) in maintaining nuclear integrity during RNA release.
• To assess the functional competence of released poly(A)+ RNA in protein synthesis.

Main Methods:

• Purification of prelabeled rat liver nuclei.
• Incubation in two in vitro RNA transport assays with and without PVP and ATP.
• Analysis of nuclear RNA sequence compartmentation.
• Assessment of in vitro protein synthesis directed by released poly(A)+ RNA.
• Treatment of rats with thioacetamide to induce hepatocarcinogenesis.

Main Results:

• Polyvinylpyrrolidone (PVP) maintained nuclear compartmentation and prevented swelling.
• Poly(A)+ RNA released with PVP and ATP was more active in protein synthesis.
• Excised introns remained nucleus-restricted, while processing catabolites were released.
• Hepatocarcinogen treatment disrupted nuclear RNA transport, mirroring in vivo observations.

Conclusions:

• The developed in vitro assay effectively models nucleocytoplasmic RNA transport.
• Poly(A)+ RNA released under physiological conditions is functionally competent.
• The assay is a valuable tool for studying RNA transport alterations in carcinogenesis.
• This system provides insights into early events in cancer development related to RNA transport.